Phylogenetic, molecular and drug-sensitivity analysis of HA and NA genes of human H3N2 influenza A viruses in Guangdong, China, 2007-2011

Epidemiology and Infection

Volumn 141, Issue 5, 2013, Pages 1061-1069

  Huang, P ^a,b   Liang, L J ^a,b   Hou, N M ^a   Zhang, X ^a   Su, W Z ^a   Yu, S Y ^c   Zhang, Y H ^a   Wu, J ^a   Chen, W Q ^b  

^a GUANGZHOU CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Drug sensitivity; epitope; H3N2; influenza; molecular epidemiology; phylogenetic analysis

Indexed keywords

EPITOPE; INFLUENZA VIRUS HEMAGGLUTININ; OSELTAMIVIR; SIALIDASE; ZANAMIVIR;

AMINO ACID SUBSTITUTION; ANTIGENICITY; ANTIVIRAL SUSCEPTIBILITY; ARTICLE; BINDING SITE; CHINA; EVOLUTIONARY RATE; GENE MUTATION; GLYCOSYLATION; HEMAGGLUTINATION INHIBITION TEST; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS HEMAGGLUTININ GENE; MOLECULAR PHYLOGENY; NONHUMAN; NUCLEOTIDE SEQUENCE; SEQUENCE ALIGNMENT; SIALIDASE GENE; STRAIN DIFFERENCE; VIRUS ISOLATION; VIRUS MUTATION; VIRUS RESISTANCE; VIRUS STRAIN;

ANTIBODIES, VIRAL; ANTIGENS, VIRAL; ANTIVIRAL AGENTS; BIOLOGICAL EVOLUTION; CHINA; DISEASE OUTBREAKS; DRUG RESISTANCE, VIRAL; GENE EXPRESSION REGULATION, VIRAL; GENETIC VARIATION; HEMAGGLUTININS, VIRAL; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; NEURAMINIDASE; PHYLOGENY; RNA, VIRAL;

EID: 84876011740     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268812001318     Document Type: Article

References (25)

1. Suwannakarn K, et al. Molecular evolution of human H1N1 and H3N2 influenza A virus in Thailand, 2006-2009. PLoS One 2010; 5: e9717.
2. Lavenu A, et al. Detailed analysis of the genetic evolution of influenza virus during the course of an epidemic. Epidemiology and Infection 2006; 134: 514-520.
3. Dawood FS, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. New England Journal of Medicine 2009; 360: 2605-2615.
4. Huang P, et al. Influenza. Guangzhou: Guangdong Technological Press 2004, pp. 89-91.
5. Skehel JJ, et al. Influenza haemagglutinin. Vaccine 2002; 20 (Suppl. 2) : S51-54.
6. Huang IC, et al. Influenza A virus neuraminidase limits viral superinfection. Journal of Virology 2008; 82: 4834-4843.
7. Huang P, et al. Molecular evolution of Guangdong influenza virus isolates in influenza outbreak in 1996. Virologica Sinica 2001; 16: 1-5.
8. Saitoh M, et al. Molecular evolution of HA1 in influenza A (H3N2) viruses isolated in Japan from 1989 to 2006. Intervirology 2008; 51: 377-384.
9. Hurt AC, et al. Oseltamivir-resistant influenza viruses circulating during the first year of the influenza A(H1N1)2009 pandemic in the Asia-Pacific region, March 2009 to March 2010. Eurosurveillance 2011; 16: pii=19770.
10. Wu W, et al. Clusters of spatial, temporal, and spacetime distribution of hemorrhagic fever with renal syndrome in Liaoning Province, Northeastern China. BMC Infectious Diseases 2011; 11: 229.
11. Blair PJ, et al. Influenza epidemiology and characterization of influenza viruses in patients seeking treatment for acute fever in Cambodia. Epidemiology and Infection 2010; 138: 199-209.
12. Tamura K, et al. MEGA5: Molecular Evolutionary Genetics Analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Molecular Biology and Evolution 2011; 28: 2731-2739.
13. Baek YH, et al. Molecular characterization and phylogenetic analysis of H3N2 human influenza A viruses in Cheongju, South Korea. Journal of Microbiology 2009; 47: 91-100.
14. Sheu TG, et al. Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008. Antimicrobial Agents and Chemotherapy 2008; 52: 3284-3892.
15. Yen HL, et al. Importance of neuraminidase active-Site residues to the neuraminidase inhibitor resistance of influenza viruses. Journal of Virology 2006; 80: 8787-8795.
16. Ding X, et al. Amino acid sequence analysis and identification of mutations under positive selection in hemagglutinin of 2009 influenza A (H1N1) isolates. Virus Genes 2010; 41: 329-340.
17. Wile DC, et al. Structural dentification of the antibodybinding sites of Hong Kong influenza hemagglutinin and their involvement in antigentic variation. Nature 1981; 289: 373-378.
18. Weis W, et al. Structure of the influenza virus hemagglutinin complexed with its receptor, sialic acid. Nature 1998; 333: 426-431.
19. Colman PM, et al. Structure of the catalytic and antigenic sites in influenza virus neuraminidase. Nature 1983; 303: 41-44.
20. Liang L, et al. Epitope peptides of influenza H3N2 neuraminidase gene designed by immunoinformatics. Acta Biochimica et Biophysica Sinica 2012; 44: 113-118.
21. Zhong J, et al. Antigenic epitope peptides of influenza H3N2 virus neuraminidase gene based on experiments. Chinese Science Bulletin 2012; 57: 2908-2913.
22. Huang JW, et al. Changed epitopes drive the antigenic drift for influenza A (H3N2) viruses. BMC Bioinformatics 2011; 12 (Suppl. 1) : S31.
23. Pan K, et al. Selective pressure to increase charge in immuno-dominant epitopes of the H3 hemagglutinin influenza protein. Journal of Molecular Evolution 2011; 72: 90-103.
24. Arinaminpathy N, et al. Dynamics of Glycoprotein Charge in the Evolutionary History of Human Influenza. PLos One 2011; 5: e15674.
25. Centers for Disease Control and Prevention. Prevention and control of influenza with vaccines : recommendations of the advisory committee on immunization practices (ACIP), 2011. Morbidity and Mortality Weekly Report 2011; 60: 1128-1132.